Cargando…

Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients

BACKGROUND: In Head and neck cancer (HNC) angiogenesis is essential for tumor progression and metastasis. Small extracellular vesicles (sEVs) from HNC cell lines alter endothelial cell (EC) functions towards a pro-angiogenic phenotype. However, the role of plasma sEVs retrieved from HNC patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tengler, Luisa, Schütz, Julia, Tiedtke, Moritz, Jablonska, Jadwiga, Theodoraki, Marie-Nicole, Nitschke, Katja, Weiß, Christel, Seiz, Elena, Affolter, Annette, Jungbauer, Frederic, Lammert, Anne, Rotter, Nicole, Ludwig, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207688/
https://www.ncbi.nlm.nih.gov/pubmed/37226100
http://dx.doi.org/10.1186/s10020-023-00659-w
_version_ 1785046512599826432
author Tengler, Luisa
Schütz, Julia
Tiedtke, Moritz
Jablonska, Jadwiga
Theodoraki, Marie-Nicole
Nitschke, Katja
Weiß, Christel
Seiz, Elena
Affolter, Annette
Jungbauer, Frederic
Lammert, Anne
Rotter, Nicole
Ludwig, Sonja
author_facet Tengler, Luisa
Schütz, Julia
Tiedtke, Moritz
Jablonska, Jadwiga
Theodoraki, Marie-Nicole
Nitschke, Katja
Weiß, Christel
Seiz, Elena
Affolter, Annette
Jungbauer, Frederic
Lammert, Anne
Rotter, Nicole
Ludwig, Sonja
author_sort Tengler, Luisa
collection PubMed
description BACKGROUND: In Head and neck cancer (HNC) angiogenesis is essential for tumor progression and metastasis. Small extracellular vesicles (sEVs) from HNC cell lines alter endothelial cell (EC) functions towards a pro-angiogenic phenotype. However, the role of plasma sEVs retrieved from HNC patients in this process is not clear so far. METHODS: Plasma sEVs were isolated on size exclusion chromatography columns from 32 HNC patients (early-stage UICC I/II: 8, advanced-stage UICC III/IV: 24), 12 patients with no evident disease after therapy (NED) and 16 healthy donors (HD). Briefly, sEVs were characterized by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), BCA protein assays and Western blots. Levels of angiogenesis-associated proteins were determined using antibody arrays. The interaction of fluorescently-labeled sEVs with human umbilical vein ECs was visualized by confocal microscopy. The functional effect of sEVs on tubulogenesis, migration, proliferation and apoptosis of ECs was assessed. RESULTS: The internalization of sEVs by ECs was visualized using confocal microscopy. Based on antibody arrays, all plasma sEVs were enriched in anti-angiogenic proteins. HNC sEVs contained more pro-angiogenic MMP-9 and anti-angiogenic proteins (Serpin F1) than HD sEVs. Interestingly, a strong inhibition of EC function was observed for sEVs from early-stage HNC, NED and HD. In contrast, sEVs from advanced-stage HNC showed a significantly increased tubulogenesis, migration and proliferation and induced less apoptosis in ECs than sEVs from HD. CONCLUSIONS: In general, plasma sEVs carry a predominantly anti-angiogenic protein cargo and suppress the angiogenic properties of ECs, while sEVs from (advanced-stage) HNC patients induce angiogenesis compared to HD sEVs. Thus, tumor-derived sEVs within the plasma of HNC patients might shift the angiogenic switch towards angiogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00659-w.
format Online
Article
Text
id pubmed-10207688
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102076882023-05-25 Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients Tengler, Luisa Schütz, Julia Tiedtke, Moritz Jablonska, Jadwiga Theodoraki, Marie-Nicole Nitschke, Katja Weiß, Christel Seiz, Elena Affolter, Annette Jungbauer, Frederic Lammert, Anne Rotter, Nicole Ludwig, Sonja Mol Med Research Article BACKGROUND: In Head and neck cancer (HNC) angiogenesis is essential for tumor progression and metastasis. Small extracellular vesicles (sEVs) from HNC cell lines alter endothelial cell (EC) functions towards a pro-angiogenic phenotype. However, the role of plasma sEVs retrieved from HNC patients in this process is not clear so far. METHODS: Plasma sEVs were isolated on size exclusion chromatography columns from 32 HNC patients (early-stage UICC I/II: 8, advanced-stage UICC III/IV: 24), 12 patients with no evident disease after therapy (NED) and 16 healthy donors (HD). Briefly, sEVs were characterized by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), BCA protein assays and Western blots. Levels of angiogenesis-associated proteins were determined using antibody arrays. The interaction of fluorescently-labeled sEVs with human umbilical vein ECs was visualized by confocal microscopy. The functional effect of sEVs on tubulogenesis, migration, proliferation and apoptosis of ECs was assessed. RESULTS: The internalization of sEVs by ECs was visualized using confocal microscopy. Based on antibody arrays, all plasma sEVs were enriched in anti-angiogenic proteins. HNC sEVs contained more pro-angiogenic MMP-9 and anti-angiogenic proteins (Serpin F1) than HD sEVs. Interestingly, a strong inhibition of EC function was observed for sEVs from early-stage HNC, NED and HD. In contrast, sEVs from advanced-stage HNC showed a significantly increased tubulogenesis, migration and proliferation and induced less apoptosis in ECs than sEVs from HD. CONCLUSIONS: In general, plasma sEVs carry a predominantly anti-angiogenic protein cargo and suppress the angiogenic properties of ECs, while sEVs from (advanced-stage) HNC patients induce angiogenesis compared to HD sEVs. Thus, tumor-derived sEVs within the plasma of HNC patients might shift the angiogenic switch towards angiogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00659-w. BioMed Central 2023-05-24 /pmc/articles/PMC10207688/ /pubmed/37226100 http://dx.doi.org/10.1186/s10020-023-00659-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Tengler, Luisa
Schütz, Julia
Tiedtke, Moritz
Jablonska, Jadwiga
Theodoraki, Marie-Nicole
Nitschke, Katja
Weiß, Christel
Seiz, Elena
Affolter, Annette
Jungbauer, Frederic
Lammert, Anne
Rotter, Nicole
Ludwig, Sonja
Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
title Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
title_full Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
title_fullStr Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
title_full_unstemmed Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
title_short Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
title_sort plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207688/
https://www.ncbi.nlm.nih.gov/pubmed/37226100
http://dx.doi.org/10.1186/s10020-023-00659-w
work_keys_str_mv AT tenglerluisa plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT schutzjulia plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT tiedtkemoritz plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT jablonskajadwiga plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT theodorakimarienicole plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT nitschkekatja plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT weißchristel plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT seizelena plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT affolterannette plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT jungbauerfrederic plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT lammertanne plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT rotternicole plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients
AT ludwigsonja plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients